DongKook Pharmaceutical Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was KRW 1,606.28 million compared to KRW 5,387.57 million a year ago. Net income was KRW 12,134.31 million compared to KRW 11,816.95 million a year ago. Basic earnings per share from continuing operations was KRW 276 compared to KRW 269 a year ago. Diluted earnings per share from continuing operations was KRW 271 compared to KRW 264 a year ago. Basic earnings per share was KRW 276 compared to KRW 269 a year ago. Diluted earnings per share was KRW 271 compared to KRW 264 a year ago.
For the nine months, sales was KRW 9,516.92 million compared to KRW 17,468.61 million a year ago. Net income was KRW 38,109.72 million compared to KRW 43,531.34 million a year ago. Basic earnings per share from continuing operations was KRW 867 compared to KRW 990 a year ago. Diluted earnings per share from continuing operations was KRW 852 compared to KRW 973 a year ago. Basic earnings per share was KRW 867 compared to KRW 990 a year ago. Diluted earnings per share was KRW 852 compared to KRW 973 a year ago.